Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
Prevalence of viral infection in a cohort with acute respiratory failure Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013
Acute respiratory failure: 7 years after monolateral lung transplant for COPD Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018
Pulmonary function in the rehabilitation period of severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 223s Year: 2004
Outcome of severe pneumonia: respiratory failure matters Source: Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?" Year: 2012
Predictors of hypoxic respiratory failure in COPD patients during 30 months of follow-up Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise Year: 2010
NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? Source: ERJ Open Res, 6 (4) 00542-2020; 10.1183/23120541.00542-2020 Year: 2020
Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Relapse of respiratory insufficiency one year after organising pneumonia Source: Eur Respir J 2004; 24: 1062-1065 Year: 2004
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia Source: Annual Congress 2013 –Interesting research questions Year: 2013
Respiratory diseases and symptoms in children hospitalized for lower respiratory tract infections during infancy: one year follow-up Source: Eur Respir J 2002; 20: Suppl. 38, 192s Year: 2002
Predictors of outcome for patients with severe hypercapnic respiratory failure requiring NIV Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013
Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004
Acute respiratory failure during pregnancy Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=241 Year: 2006
Respiratory development of children experiencing a first RSV brochiolitis episode before age one Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Acute viral respiratory tract infections and wheezing at follow-up in children < 3 years Source: International Congress 2015 – Respiratory infections in children Year: 2015
Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009